Yungjin Pharm. Co., Ltd. (KRX: 003520)

Yungjin Pharm. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Nov 15, 2024	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Market Capitalization	375,844	287,744	348,135	150,622	145,500	92,268
Market Cap Growth	7.30%	-17.35%	131.13%	3.52%	57.69%	-33.17%
Enterprise Value	382,297	311,216	366,840	163,118	185,784	128,217
Last Close Price	2055.00	1620.00	1960.00	848.00	1091.83	692.38
PE Ratio	38.42	162.00	130.67	-	-	-
PS Ratio	2.06	2.09	3.11	1.29	1.41	0.83
PB Ratio	3.69	3.16	3.87	1.64	2.39	1.44
P/TBV Ratio	3.70	3.30	4.03	1.70	2.54	1.52
P/FCF Ratio	314.84	-	-	-	-	19.00
P/OCF Ratio	56.09	120.94	40.97	-	-	8.95
EV/Sales Ratio	2.41	2.26	3.27	1.40	1.80	1.16
EV/EBITDA Ratio	26.40	39.42	45.53	39.06	66.49	33.33
EV/EBIT Ratio	38.84	95.24	89.79	403.32	-	313.92
EV/FCF Ratio	320.24	-	-	-	-	26.40
Debt / Equity Ratio	0.28	0.27	0.31	0.35	0.77	0.63
Debt / EBITDA Ratio	1.94	3.16	3.46	7.68	16.85	10.47
Debt / FCF Ratio	23.50	-	-	-	-	8.30
Asset Turnover	0.94	0.86	-	-	0.74	0.89
Inventory Turnover	3.12	3.27	-	-	2.77	3.09
Quick Ratio	1.20	1.18	1.18	-	0.66	0.75
Current Ratio	2.06	1.95	1.86	-	1.44	1.48
Return on Equity (ROE)	9.00%	1.98%	2.84%	-3.02%	-6.96%	-10.51%
Return on Assets (ROA)	3.63%	1.28%	-	-	-0.29%	0.20%
Return on Capital (ROIC)	5.01%	1.75%	2.11%	0.22%	-0.38%	0.27%
Earnings Yield	2.60%	0.62%	0.74%	-1.53%	-2.99%	-6.34%
FCF Yield	0.32%	-0.27%	-1.53%	-	-2.50%	5.26%
Buyback Yield / Dilution	14.83%	-4.28%	-	-	-	-19.10%
Total Shareholder Return	14.83%	-4.28%	-	-	-	-19.10%

Source: S&P Capital IQ. Standard template. Financial Sources.